Vicore Pharma Holding AB

VICO.ST · Health Technology · Biotechnology · SE

26 employees · vicorepharma.com

About

Vicore Pharma Holding AB, headquartered in Stockholm, Sweden, is a biotechnology company focused on developing drugs for interstitial lung diseases and related conditions. The company, listed on the stock market since December 10, 2015, employs 26 full-time staff and operates within the Health Care sector. Its portfolio includes small molecules targeting anti-inflammation, nerve regeneration, and cardiovascular diseases, with a wholly owned subsidiary structure under Mintage Scientific AB.

Annual results

Reported figures, SEK

YearRevenueNet incomeNet marginFree cash flow
2024109M-168M-154.1%—
2023—-310M——
2022—-288M——
2021—-296M——
2020—-146M——

VICO.ST in MarketPulse

The live chart with RSI and moving averages, the price, news, signals and price alerts for Vicore Pharma Holding AB are inside MarketPulse — currently in private beta.

Company data by Eulerpool. Logos provided by Elbstream. Reported figures, not investment advice.

Vicore Pharma Holding AB (VICO.ST) — company profile and financials · MarketPulse